Post by Canaccord Genuity Australia

Canaccord Genuity is pleased to have acted as Joint Lead Manager & Underwriter to a A$150 million equity raising for EBR Systems (ASX: EBR). Proceeds from the equity raising will be used to accelerate the commercial rollout of EBR Systems' WiSE cardiac resynchronisation therapy system, including sales expansion, manufacturing scale-up and ongoing product development. Congratulations to Allan Will, John McCutcheon, Gary Doherty, Andrew Shute and the entire EBR Systems, Inc. team on a successful transaction. CG’s Investment banking team was led by Carlee Szakiel, Tyler Verbeek, Joshua Seddon and Jack McCorkell. ECM/Syndication by Alex U..